JPRN-UMIN000002451已完成未知
Phase II trial of Pemetrexed and Carboplatin for advanced non-squamous non-small cell lung cancer - Phase II trial of PEM+CBDCA for non-sq NSCLC
Kyoto Thoracic Oncology Research Group0 个研究点目标入组 50 人开始时间: 2010年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)active concomitant malignancy 2)pregnant or lactating woman 3)psychiatry disease 4)interstitial pneumoia/active lung fibrosis on chest x-ray 5)symptomatic brain metastasis 6)massive or uncontrolable pleural effusion 7)uncontrolable diabetes mellitus 8)uncontrolable hypertension 9)unstable angina or myocardial infarction within 6 months 10)history of severe drug allergy
研究者
相似试验
已完成
1 期
Phase I/II trial of pemetrexed + carboplatin followed by maintenance pemetrexed therapy in elderly patients with advanced non-small cell lung cancerJPRN-UMIN0000048101:Osaka Prefectural Medical Center for Respiratory and Allergic Diseases 2:Kinki-Chuo chest medical center50
已完成
2 期
A Phase 2 study of pemetrexed and carboplatin for platinum-pretreated patients with non small cell lung cancerplatinum pretreated patients with non small cell lung cancerJPRN-UMIN000005552Osaka Prefectural Medical Center for Respiratory and Allergic deseases30
已完成
2 期
Phase II study of Pemetrexed + Carboplatin as first line therapy for nonsquamous non-small cell lung cancer with interstitial pneumoniaJPRN-UMIN000011325Central Japan Lung Study Group (CJLSG)25
已完成
2 期
Phase 2 study of Pemetrexed + Carboplatin as first line therapy for non-squamous non-small cell lung cancer without EGFR Mutation (CJLSG0906)JPRN-UMIN000003393Central Japan Lung Study Group53
已完成
2 期
Phase 2 study of Pemetrexed + Carboplatin as first line therapy for non-squamous non-small cell lung cancer with EGFR Mutation (CJLSG0907)JPRN-UMIN000003394Central Japan Lung Study Group23